{
  "meta": {
    "title": "20_Basics_Of_Hemolysis_And_Intravascular_Hemolysis",
    "url": "https://brainandscalpel.vercel.app/20-basics-of-hemolysis-and-intravascular-hemolysis-04cf8833.html",
    "scrapedAt": "2025-11-30T12:33:28.280Z"
  },
  "questions": [
    {
      "text": "Match the types of hemoglobin with their globin chains.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Hemoglobin</strong></td>\n<td><strong>Globin chains</strong></td>\n</tr>\n<tr>\n<td>1. HbF</td>\n<td>A. &alpha; and &beta;</td>\n</tr>\n<tr>\n<td>2. HbA</td>\n<td>B. &alpha; and &delta;</td>\n</tr>\n<tr>\n<td>3. HbA2</td>\n<td>C. &alpha; and &gamma;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-B, 2-A, 3-C"
        },
        {
          "id": 2,
          "text": "1-C, 2-A, 3-B"
        },
        {
          "id": 3,
          "text": "1-C, 2-B, 3-A"
        },
        {
          "id": 4,
          "text": "1-A, 2-B, 3-C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The types of hemoglobin along with their globin chains are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Hemoglobin</strong></td>\n<td><strong>Components</strong></td>\n</tr>\n<tr>\n<td>HbF</td>\n<td>&alpha;2&gamma;2</td>\n</tr>\n<tr>\n<td>HbA</td>\n<td>&alpha;2&beta;2</td>\n</tr>\n<tr>\n<td>HbA2</td>\n<td>&alpha;2&delta;2</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The image given below shows the graphical representation of the globin chain synthesis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/58cda96961ec4c02aedddc913b5529a5x1280x1121.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0302",
      "difficulty": "easy"
    },
    {
      "text": "Enzyme deficiency in which of the following pathways can cause hemolysis?",
      "choices": [
        {
          "id": 1,
          "text": "Orotic acid pathway"
        },
        {
          "id": 2,
          "text": "Glycolysis"
        },
        {
          "id": 3,
          "text": "Fatty acid synthesis"
        },
        {
          "id": 4,
          "text": "Polyol pathway"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Enzyme deficiency</strong> in the <strong>glycolytic pathway</strong> can cause <strong>hemolysis</strong>.</p>\n<p>The following enzyme deficiencies can cause hemolysis:</p>\n<p>In the <strong>glycolytic</strong> pathway:</p>\n<ul>\n<li>Pyruvate kinase deficiency</li>\n<li>Hexokinase deficiency</li>\n</ul>\n<p>In the <strong>HMP shunt</strong> pathway:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Glutathione synthetase deficiency</li>\n</ul>\n<p>Note: Orotic aciduria causes megaloblastic anaemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0287",
      "difficulty": "medium"
    },
    {
      "text": "What is the normal reticulocyte count?",
      "choices": [
        {
          "id": 1,
          "text": "0.5–1.5%"
        },
        {
          "id": 2,
          "text": "2.5–5%"
        },
        {
          "id": 3,
          "text": "5–10%"
        },
        {
          "id": 4,
          "text": "1.5–2.5%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Normal <strong>reticulocyte</strong> <strong>count</strong> is <strong>0.5–1.5%</strong> of total red cells. </p>\n<p>Causes of <strong>increased</strong> reticulocyte count:</p>\n<ul>\n<li>Hemolytic anaemia</li>\n<li>Acute and chronic blood loss</li>\n</ul>\n<p>Causes of <strong>decreased</strong> reticulocyte count:</p>\n<ul>\n<li>Iron deficiency anaemia</li>\n<li>Megaloblastic anaemia</li>\n<li>Aplastic anaemia</li>\n<li>Anaemia of chronic diseases</li>\n<li>Myelodysplastic syndromes</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0289",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about reticulocytes?",
      "choices": [
        {
          "id": 1,
          "text": "They are nucleated"
        },
        {
          "id": 2,
          "text": "They contain ribosomal RNA"
        },
        {
          "id": 3,
          "text": "They are larger in size than red cell"
        },
        {
          "id": 4,
          "text": "Their normal count is 0.5-1.5%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Reticulocytes</strong> are <strong>red cell precursors</strong>, which are non-nucleated.&nbsp;</p>\n<p>They have <strong>blue-red</strong> polychromatophilic <strong>cytoplasm</strong> due to the presence of a reticular (mesh-like) network of ribosomal RNA. They can be visualized using&nbsp;<strong>supravital stains</strong>&nbsp;like methylene blue and&nbsp;brilliant cresyl blue,&nbsp;which stain the ribosomal RNA.&nbsp;</p>\n<p><strong>Reticulocytosis</strong> (increased reticulocytes) indicates <strong>effective erythropoiesis</strong> i.e. good bone marrow response to anaemia. It is seen in:</p>\n<ul>\n<li>Hemolytic anaemias</li>\n<li>Acute blood loss</li>\n</ul>\n<p><strong>Reticulocytopenia</strong> (decreased reticulocytes) indicates <strong>ineffective&nbsp;erythropoiesis</strong> i.e. poor bone marrow response to anaemia. It is seen in:</p>\n<ul>\n<li>Chemotherapy</li>\n<li>Aplastic anaemia</li>\n<li>Bone marrow malignancy</li>\n<li>Anaemia of chronic disease</li>\n<li>Iron-deficiency anaemia</li>\n<li>Vitamin B12 and folate deficiency</li>\n</ul>\n<p>The peripheral smear shows reticulocytosis and spherocytosis&nbsp;seen in non-Hodgkin lymphoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/828c0cc5c2f64206a6a2d2653a3117a8x540x539.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0403",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old woman had severe blood loss during delivery 2-days ago. Her current hemoglobin is 5 gm/dL and reticulocyte count is 9%. What is her corrected reticulocyte count?",
      "choices": [
        {
          "id": 1,
          "text": "6"
        },
        {
          "id": 2,
          "text": "4.5"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "0.5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given scenario, the corrected reticulocyte count is <strong>3</strong>.</p>\n<p>It is given by the following formula:</p>\n<p><strong>Corrected reticulocyte count</strong> = Reticulocyte count &times; (patient's hemoglobin or hematocrit &frasl; standard hemoglobin or hematocrit)</p>\n<p>So, in this case, the corrected reticulocyte count = 9&times;5/15&nbsp; = 9/3&nbsp; = 3</p>\n<p>This formula corrects for hemoglobin. It will show you if the patient is making enough reticulocytes for the degree of anemia present. As the hemoglobin drops, reticulocytes increase from the normal range of 0.5&ndash;2.0%.</p>\n<p>The standard reference range of hemoglobin concentration in females is 12-15 g/dl. Accordingly, in this scenario, corrected reticulocyte count would range between 3-3.75%. So, the best answer to this question remains option C.</p>\n<p><strong>Absolute reticulocyte count&nbsp;</strong>is the&nbsp;percentage of red cells that are reticulocytes (normal is about 0.5 &ndash; 2.0%). However, it does not reflect the fact that as the hemoglobin drops, there should be more reticulocytes, percentage-wise (for example, at a hemoglobin of 5, you should have a much higher percentage of reticulocytes than you should at a hemoglobin of 10). To take this into account, we use corrected reticulocyte count.</p>\n<p><strong>Reticulocyte Index</strong> = Corrected reticulocyte count / maturation factor</p>\n<p>This corrects for the longer life span of prematurely released reticulocytes in the blood which is a phenomenon of increased red blood cell production.</p>\n<table>\n<tbody>\n<tr>\n<td>Hematocrit</td>\n<td>Maturation factor</td>\n</tr>\n<tr>\n<td>&ge; 35%</td>\n<td>1.0</td>\n</tr>\n<tr>\n<td>35% &gt; Hct &ge; 25%</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>25% &gt; Hct &ge; 20%</td>\n<td>2.0</td>\n</tr>\n<tr>\n<td>&lt; 20%</td>\n<td>2.5&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0413",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with microcytic hypochromic anaemia, red cell distribution width was measured. What is this parameter used to identify?",
      "choices": [
        {
          "id": 1,
          "text": "Anisocytosis"
        },
        {
          "id": 2,
          "text": "Poikilocytosis"
        },
        {
          "id": 3,
          "text": "Anisochromia"
        },
        {
          "id": 4,
          "text": "Biconcavity"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Red cell distribution width (<strong>RDW</strong>) deals with <strong>anisocytosis</strong> of RBCs.&nbsp;It refers to the <strong>unequal size</strong> of the RBCs.</p>\n<p><strong>Normal values</strong> are:&nbsp;</p>\n<ul>\n<li>RDW-SD (Standard deviation) - 39-46 fL</li>\n<li>RDW-CV (Coefficient of variation) - 11.6-14.6%</li>\n</ul>\n<p>RDW is of great <strong>use</strong> in two clinical situations. They are:</p>\n<ul>\n<li>To <strong>differentiate</strong> between <strong>thalassemia</strong> and iron deficiency anaemia (<strong>IDA</strong>)\n<ul>\n<li>Thalassemia - the RBCs are small (low MCV) and of uniform size (normal RDW)</li>\n<li>IDA - the RBCs are small (low MCV) but vary greatly in size (high RDW).</li>\n</ul>\n</li>\n<li>To <strong>diagnose</strong> <strong>dimorphic</strong> anaemia (anaemia due to both iron and vitamin B12 deficiency)<br />\n<ul>\n<li>High RDW</li>\n<li>Normal MCV</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0408",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not increased in intravascular hemolysis?",
      "choices": [
        {
          "id": 1,
          "text": "Lactate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Free hemoglobin"
        },
        {
          "id": 3,
          "text": "Methemoglobin"
        },
        {
          "id": 4,
          "text": "Haptoglobin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Haptoglobin</strong> is <strong>decreased</strong> in intravascular hemolysis.</p>\n<p>Types of hemolysis based on location:</p>\n<ul>\n<li>Intravascular hemolysis -&nbsp;hemolysis that occurs mainly within the&nbsp;blood vessels</li>\n<li>Extravascular hemolysis -&nbsp;hemolysis that occurs via macrophages of the reticuloendothelial system in the spleen, liver, bone marrow, and lymph nodes</li>\n</ul>\n<p><strong>Features</strong> of <strong>intravascular</strong> hemolysis are:</p>\n<ul>\n<li>Decreased haptoglobin</li>\n<li>Increased lactate dehydrogenase&nbsp;</li>\n<li>Hemoglobinemia</li>\n<li>Hemoglobinuria</li>\n<li>Hemosiderinuria</li>\n<li>Methemoglobinemia</li>\n<li>Methemoglobinuria</li>\n<li>Indirect hyperbilirubinemia</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f4d65a90fa944128bade078a3cb65243x1280x2389.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0288",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following does not cause intravascular hemolysis?",
      "choices": [
        {
          "id": 1,
          "text": "Paroxysmal nocturnal hemoglobinuria"
        },
        {
          "id": 2,
          "text": "Thrombotic thrombocytopenic purpura"
        },
        {
          "id": 3,
          "text": "Infection"
        },
        {
          "id": 4,
          "text": "Thalassemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Thalassemia</strong> causes <strong>extravascular</strong> hemolysis.</p>\n<p><strong>Causes </strong>of<strong> intravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li><span class=\"TextRun SCXW225898103\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW225898103\">Mechanical injury</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Trauma caused by cardiac valves&nbsp;</li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Microangiopathic&nbsp;hemolytic&nbsp;anaemias&nbsp;(hemolytic&nbsp;uremic syndrome,&nbsp;disseminated intravascular coagulation, <strong>thrombotic thrombocytopenic&nbsp;purpura&nbsp;</strong>)&nbsp;</li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Repetitive physical trauma</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW46333709\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW46333709\">Complement fixation (antibody-mediated destruction)</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Hemolytic&nbsp;disease of the&nbsp;newborn&nbsp;</li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Transfusion reaction&nbsp;&nbsp;</li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Drug-induced&nbsp;</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\"><strong>Infections</strong> of red blood cells&nbsp;</span></span>\n<ul>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Malaria </span></span></li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">B</span></span><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW127641793\">abesiosis</span></span></li>\n</ul>\n</li>\n<li><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">Exogenous toxic factors&nbsp;-&nbsp;</span></span></span><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">C</span></span><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW261552469\">lostridial</span></span><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">&nbsp;sepsis</span></span></span></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Causes </strong>of<strong> extravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li><strong>Thalassemia</strong></li>\n<li>Sickle cell anaemia</li>\n</ul>\n<p><strong>Causes</strong> of <strong>both</strong> intravascular and extravascular:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Autoimmune hemolytic anaemia</li>\n</ul>\n</div>\n</div><hr><h3>Related Pearl: Classification of Hemolytic Anemias</h3><p>Hemolytic anemias can be classified in 2 ways:</p>\n<p>1. Based on the <strong>type of defect</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type </strong></td>\n<td><strong>Intracorpuscular Defects</strong></td>\n<td><strong>Extracorpuscular Factors</strong></td>\n</tr>\n<tr>\n<td>Hereditary</td>\n<td>\n<p>Hemoglobinopathies</p>\n<p>Enzymopathies</p>\n<p>Membrane-cytoskeletal defects</p>\n</td>\n<td>Familial (atypical) hemolytic uremic syndrome</td>\n</tr>\n<tr>\n<td>Acquired</td>\n<td>Paroxysmal nocturnal hemoglobinuria (PNH)</td>\n<td>\n<p>Mechanical destruction (microangiopathic)</p>\n<p>Toxic agents</p>\n<p>Drugs</p>\n<p>Infectious</p>\n<p>Autoimmune</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>2. Based on the <strong>sites</strong> of <strong>hemolysis:</strong></p>\n<p><strong>Intravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li><span class=\"TextRun SCXW225898103\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW225898103\">Mechanical injury</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Trauma caused by cardiac valves </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Microangiopathic hemolytic anaemias (hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura) </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Repetitive physical trauma</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW46333709\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW46333709\">Complement fixation (antibody-mediated destruction)</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Hemolytic disease of the newborn- ABO incompatibility </li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Transfusion reaction  </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Drug-induced </li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Infections of red blood cells </span></span>\n<ul>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Malaria</span></span></li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">B</span></span><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW127641793\">abesiosis</span></span></li>\n</ul>\n</li>\n<li><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">Exogenous toxic factors - c</span></span></span><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW261552469\">lostridial</span></span><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\"> sepsis</span></span></span></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Extravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia</li>\n<li>Sickle cell anemia</li>\n<li>Hemolytic disease of the newborn- Rh incompatibility</li>\n</ul>\n<p><strong>Both</strong> intravascular and extravascular hemolysis:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Autoimmune hemolytic anemia</li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0290",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following pairs of mutation and involved genes describes paroxysmal nocturnal hemoglobinuria?",
      "choices": [
        {
          "id": 1,
          "text": "AD inheritance - UMOD"
        },
        {
          "id": 2,
          "text": "Acquired genetic mutation - PIGA"
        },
        {
          "id": 3,
          "text": "AR inheritance - MUC1"
        },
        {
          "id": 4,
          "text": "Acquired genetic mutation - GPI"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Paroxysmal nocturnal hemoglobinuria (<strong>PNH</strong>) is a disease that results from <strong>acquired </strong>mutations in the phosphatidylinositol glycan complementation group A gene (<strong>PIGA</strong>).</p>\n<p>This gene codes for an enzyme that is essential for the <strong>synthesis</strong> of certain membrane-associated <strong>complement</strong> <strong>regulatory</strong> <strong>proteins</strong>. It is the only hemolytic anaemia caused by an acquired genetic defect.</p>\n<p><strong>PNH</strong> blood cells are <strong>deficient</strong> in <strong>3 GPI-linked proteins</strong> that regulate complement activity:</p>\n<ul>\n<li>Decay Accelerating Factor or <strong>CD55</strong></li>\n<li>Membrane Inhibitor of Reactive Lysis or <strong>CD59</strong></li>\n<li><strong>C8-binding protein</strong></li>\n</ul>\n<p><strong>CD59,</strong>&nbsp;a potent <strong>inhibitor</strong> of <strong>C3 convertase,</strong>&nbsp;<strong>prevents</strong> the spontaneous activation of the <strong>alternative complement pathway</strong>. Red cells deficient in these GPI-linked factors are abnormally susceptible to lysis or injury by C5b-C9 membrane attack complex of the complement&nbsp;system.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0dff4dfe202446c9bbd0e9054561cd6cx1280x2392.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0319",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following cells are involved in paroxysmal nocturnal hemoglobinuria?",
      "choices": [
        {
          "id": 1,
          "text": "RBCs"
        },
        {
          "id": 2,
          "text": "RBCs and WBCs"
        },
        {
          "id": 3,
          "text": "WBCs and platelets"
        },
        {
          "id": 4,
          "text": "RBCs, WBCs and platelets"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">All three cell lines, <strong>RBCs</strong>, <strong>WBCs</strong>, and <strong>platelets</strong> are <strong>affected</strong> in paroxysmal nocturnal hemoglobinuria (<strong>PNH</strong>).</span></span></p>\n<p><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">PNH occurs from acquired mutations </span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">in the gene </span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">PIGA which affect GPI-linked proteins. T</span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">hese <strong>causative</strong> <strong>mutations</strong> occur in a <strong>hematopoietic</strong> <strong>stem</strong> <strong>cell</strong>. Hence,</span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\"> </span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">all</span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\"> </span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">of its clonal progeny,</span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\"> </span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">i.e., red cells, white cells, and platelets, </span></span><span class=\"TextRun SCXW223356147\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW223356147\">are deficient in GPI-linked proteins.</span></span></p>\n<p class=\"p1\"><strong>Clinical features</strong> of PNH include:</p>\n<ul>\n<li class=\"p1\">Intravascular hemoglobinuria - cola-colored urine</li>\n<li class=\"p1\">Pancytopenia + hypercellular bone marrow</li>\n<li class=\"p1\">Thrombosis (if hepatic vein involved → Budd–Chiari syndrome)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0380",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old man with pancytopenia is suspected to have PNH. Which of the following findings is inconsistent with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Increased LAP score"
        },
        {
          "id": 2,
          "text": "Thrombosis"
        },
        {
          "id": 3,
          "text": "Thrombocytopenia"
        },
        {
          "id": 4,
          "text": "Increased methemoglobin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In <strong>PNH</strong>, the leukocyte alkaline phosphatase&nbsp;(<strong>LAP</strong>) <strong>score</strong> is <strong>decreased.</strong></p>\n<p>Alkaline phosphatase activity is found predominantly in <strong>mature segmented neutrophils</strong>. LAP score is obtained by assessing the <strong>staining intensity</strong> in 100 consecutive neutrophils, with each neutrophil scored on a scale of 1&ndash;4.&nbsp;<strong><span class=\"hvr\">Conditions</span></strong> <span class=\"hvr\">that</span> <span class=\"hvr\">result</span> in an <strong><span class=\"hvr\">increase</span></strong> in <strong><span class=\"hvr\">leukocytes</span></strong> in <span class=\"hvr\">all</span> <span class=\"hvr\">stages</span> of <span class=\"hvr\">maturity</span> <span class=\"hvr\">will</span> <span class=\"hvr\">reflect</span> a <span class=\"hvr\">corresponding</span> <strong><span class=\"hvr\">increase</span></strong> in <span class=\"hvr\"><strong>LAP</strong>.</span></p>\n<table>\n<tbody>\n<tr>\n<td><span class=\"hvr\"><strong>Increased LAP</strong></span></td>\n<td><strong><span class=\"hvr\">Decreased LAP</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\"hvr\">Leukemoid reaction</span></li>\n<li><span class=\"hvr\">Pregnancy</span></li>\n<li><span class=\"hvr\">Polycythemia vera</span></li>\n<li><span class=\"hvr\">Hodgkin's disease</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span class=\"hvr\">CML</span></li>\n<li><span class=\"hvr\">PNH</span></li>\n<li><span class=\"hvr\">Sickle cell anemia</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2430",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is most likely the cause of death in a patient with paroxysmal nocturnal hemoglobinuria?",
      "choices": [
        {
          "id": 1,
          "text": "Sepsis"
        },
        {
          "id": 2,
          "text": "Budd-Chiari syndrome"
        },
        {
          "id": 3,
          "text": "Renal failure"
        },
        {
          "id": 4,
          "text": "Hemorrhage"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the following,<strong> Budd-Chiari Syndrome</strong> is the <strong>most likely</strong> the cause of death in a patient with paroxysmal nocturnal hemoglobinuria (PNH).</p>\n<p><strong>Thrombosis</strong> (particularly venous thrombosis) is the <strong>leading cause</strong> of <strong>disease-related death</strong> in patients with PNH. 40% of PNH patients suffer from <strong>venous thrombosis</strong>, which commonly affects the<strong> hepatic</strong>, <strong>portal</strong>, or <strong>cerebral veins</strong>.</p>\n<p>The pathophysiology of thrombosis in PNH is not completely understood, but two main mechanisms may be responsible:</p>\n<ul>\n<li>Nitric oxide (NO) is absorbed by free hemoglobin (which is released during hemolysis).</li>\n<li>Endothelial damage caused by the C5-9 membrane attack complex (due to deficiency of CD59).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0320",
      "difficulty": "medium"
    },
    {
      "text": "Flow cytometric analysis in a patient with pancytopenia shows a deficiency of GPI-linked proteins on blood cells. Which of the following is not a complication of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Deep vein thrombosis"
        },
        {
          "id": 2,
          "text": "Cryoglobulinemia"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 4,
          "text": "Myelodysplastic syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>deficiency</strong> of <strong>GPI linked proteins</strong> on blood cells is seen in&nbsp;paroxysmal nocturnal hemoglobinuria <strong>(PNH)</strong>.&nbsp;Cryoglobulinemia is not a complication of this condition.</p>\n<p><strong>Thrombosis</strong> is the leading cause of disease-related death in individuals with paroxysmal nocturnal hemoglobinuria (PNH). About 5% to 10% of patients eventually develop acute myeloid leukemia&nbsp;(<strong>AML</strong>) or <strong>myelodysplastic syndrome</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0321",
      "difficulty": "medium"
    },
    {
      "text": "What is the gold standard for the diagnosis of paroxysmal nocturnal hemoglobinuria?",
      "choices": [
        {
          "id": 1,
          "text": "Ham test"
        },
        {
          "id": 2,
          "text": "Bone marrow biopsy"
        },
        {
          "id": 3,
          "text": "HPLC"
        },
        {
          "id": 4,
          "text": "Flow cytometry"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>gold standard</strong> for the <strong>diagnosis</strong> of <strong>PNH</strong> is <strong>flow cytometry</strong>.&nbsp;It provides a sensitive means&nbsp;for detecting red cells that are deficient in GPI-linked proteins such as CD59.</p>\n<p><strong>Investigations</strong> in PNH include:</p>\n<ul>\n<li><strong>Flow cytometry </strong>(gold standard) -&nbsp;deficiency of CD59 and CD55</li>\n<li><strong>Ham test</strong>&nbsp;(acidified serum lysis) - lysis of RBCs in a mildly acidic pH due to complement fixation</li>\n<li><strong>Bone marrow biopsy </strong>-\n<ul>\n<li>Hypercellularity with erythroid hyperplasia is seen in classical presentations</li>\n<li>Patients who develop pancytopenia will have hypocellular bone marrow</li>\n</ul>\n</li>\n<li>Imaging - to evaluate venous thrombosis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0374",
      "difficulty": "medium"
    },
    {
      "text": "A 37-year-old man presents with a history of dark coloured urine in the morning for 2 months. His lab investigations and flow cytometry are given below. What is the curative therapy for this condition?<div class='question-desc-html'><p>Hb level - 3 g/dL</p>\n<p>RBC - 3 million/mm<sup>3</sup></p>\n<p>TLC - 1500 /&mu;L</p>\n<p>Platelet - 15,000 /&mu;L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Eculizumab"
        },
        {
          "id": 2,
          "text": "Immunosuppressants"
        },
        {
          "id": 3,
          "text": "Blood transfusion"
        },
        {
          "id": 4,
          "text": "Hematopoietic stem cell transplant"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>PNH</strong> (paroxysmal nocturnal hemoglobinuria).&nbsp;The <strong>curative </strong>therapy for this condition is a&nbsp;<strong>hematopoietic stem cell transplant</strong>.&nbsp;&nbsp;</p>\n<p><strong>Pancytopenia</strong> is seen in this condition. <strong>Flow cytometry</strong> shows 2 populations of red cells:</p>\n<ul>\n<li>Marked <strong>red</strong> in the left lower quadrant -&nbsp;<strong>deficient</strong> in both <strong>CD55</strong> and <strong>CD59</strong>, characteristic of <strong>PNH.</strong></li>\n<li>Marked <strong>black</strong> in the right upper quadrant - <strong>CD55+</strong> and <strong>CD59+</strong> cells from the residual normal hematopoietic cells</li>\n</ul>\n<p><strong>Eculizumab</strong>&nbsp;is a monoclonal antibody that can be used in PNH. It prevents the conversion of&nbsp;C5 to&nbsp;C5a&nbsp;and reduces&nbsp;hemolysis.<br /><strong>Immunosuppressive</strong> <strong>drugs</strong>&nbsp;are sometimes beneficial for those with evidence of&nbsp;marrow aplasia.</p>\n<p>Note:&nbsp;FDA has approved the following drugs for treatment of adults with PNH:</p>\n<ul>\n<li><strong>Ravulizumab</strong> injection, a long-acting C-5 complement inhibitor</li>\n<li><strong>Pegcetacoplan</strong>, which acts by binding to complement protein C3 and increasing hemoglobin concentration</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d7cc11a7646f4d32b87eb44ade0ac2a8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0377",
      "difficulty": "medium"
    }
  ]
}